Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Paul Morgan

Showing results (11-20 of 249) with videos related to

Pageof 25
Sort By:
Clinical Science (London, England : 1979)|February 13, 2003
Beyond lysis: how complement influences cell fateDuncan S Cole, B Paul Morgan
Frontiers in Immunology|January 11, 2021
Monoclonal Antibodies Capable of Inhibiting Complement Downstream of C5 in Multiple SpeciesWioleta M Zelek, B Paul Morgan
Molecular Immunology|August 14, 2003
Complement therapeutics; history and current progressB Paul Morgan, Claire L Harris
Nature Reviews. Drug Discovery|October 24, 2015
Complement, a target for therapy in inflammatory and degenerative diseasesB Paul Morgan, Claire L Harris
Marine Drugs|August 2, 2012
Exploiting the nephrotoxic effects of venom from the sea anemone, Phyllodiscus semoni, to create a hemolytic uremic syndrome model in the ratMasashi Mizuno, Yasuhiko Ito, B Paul Morgan
Seminars in Cell & Developmental Biology|June 26, 2017
Molecular cell biology of complement membrane attackB Paul Morgan, Courtney Boyd, Doryen Bubeck
Frontiers in Cellular Neuroscience|January 25, 2021
An "Outside-In" and "Inside-Out" Consideration of Complement in the Multiple Sclerosis Brain: Lessons From Development and Neurodegenerative DiseasesB Paul Morgan, Jennifer L Gommerman, Valeria Ramaglia
Journal of Reproductive Immunology|December 29, 2005
Spermatogenic cells distal to the blood-testis barrier in rats lack C3 convertase regulators and may be at risk of complement-mediated injuryMasashi Mizuno, Claire L Harris, B Paul Morgan
Molecular Immunology|July 26, 2005
Letter in response to A. Agrawal: 'CRP after 2004'Carmen W van den Berg, B Paul Morgan
Molecular Immunology|August 4, 2006
Alternative roles for CD59Fiona C Kimberley, Baalasubramanian Sivasankar, B Paul Morgan
Pageof 25

Showing results (11-20 of 249) with videos related to

Sort By:
Pageof 25
Clinical Science (London, England : 1979)|February 13, 2003
Beyond lysis: how complement influences cell fateDuncan S Cole, B Paul Morgan
Frontiers in Immunology|January 11, 2021
Monoclonal Antibodies Capable of Inhibiting Complement Downstream of C5 in Multiple SpeciesWioleta M Zelek, B Paul Morgan
Molecular Immunology|August 14, 2003
Complement therapeutics; history and current progressB Paul Morgan, Claire L Harris
Nature Reviews. Drug Discovery|October 24, 2015
Complement, a target for therapy in inflammatory and degenerative diseasesB Paul Morgan, Claire L Harris
Marine Drugs|August 2, 2012
Exploiting the nephrotoxic effects of venom from the sea anemone, Phyllodiscus semoni, to create a hemolytic uremic syndrome model in the ratMasashi Mizuno, Yasuhiko Ito, B Paul Morgan
Seminars in Cell & Developmental Biology|June 26, 2017
Molecular cell biology of complement membrane attackB Paul Morgan, Courtney Boyd, Doryen Bubeck
Frontiers in Cellular Neuroscience|January 25, 2021
An "Outside-In" and "Inside-Out" Consideration of Complement in the Multiple Sclerosis Brain: Lessons From Development and Neurodegenerative DiseasesB Paul Morgan, Jennifer L Gommerman, Valeria Ramaglia
Journal of Reproductive Immunology|December 29, 2005
Spermatogenic cells distal to the blood-testis barrier in rats lack C3 convertase regulators and may be at risk of complement-mediated injuryMasashi Mizuno, Claire L Harris, B Paul Morgan
Molecular Immunology|July 26, 2005
Letter in response to A. Agrawal: 'CRP after 2004'Carmen W van den Berg, B Paul Morgan
Molecular Immunology|August 4, 2006
Alternative roles for CD59Fiona C Kimberley, Baalasubramanian Sivasankar, B Paul Morgan
Pageof 25